Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mind Medicine Mindmed Inc
(NQ:
MNMD
)
9.260
+0.140 (+1.54%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Mind Medicine Mindmed Inc
< Previous
1
2
3
4
Next >
FCM Nominates Exceptional Director Candidates to Restore MindMed’s Value
April 21, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting
April 18, 2023
From
MindMed
Via
Business Wire
MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)
April 14, 2023
From
MindMed
Via
Business Wire
MindMed Appoints Mark R. Sullivan as Chief Legal Officer and Corporate Secretary
April 13, 2023
From
MindMed
Via
Business Wire
MindMed Reports Full Year 2022 Financial Results and Business Highlights
March 09, 2023
From
MindMed
Via
Business Wire
MindMed to Participate in March Investor Conferences
February 28, 2023
From
MindMed
Via
Business Wire
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
January 26, 2023
EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Economy
Exposures
Supply Chain
Three Trends That May Shape the Psychedelics Industry Next Year
January 03, 2023
Via
Investor Brand Network
Activist Investor Informs MindMed of Financial Misstatements, Questions Internal Controls
November 14, 2022
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
Significant MindMed Investor Demands Federal Investigation to Probe Serious Allegations of Misconduct
November 03, 2022
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
Psychedelic Drugs Prove Their Worth In Clinical Trials
October 11, 2022
Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial...
Via
PressReach
Colorado to Vote on Legalizing Psychoactives in November
October 05, 2022
Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the...
Via
PressReach
Topics
Supply Chain
Exposures
Supply Chain
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City...
Via
PressReach
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one...
Via
FinancialNewsMedia
Psychedelics May Make People Less Afraid of Death
September 07, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change...
Via
FinancialNewsMedia
Topics
Supply Chain
Exposures
Supply Chain
Study Suggests LSD May Boost Learning, Memory by Enhancing Neural Plasticity
August 18, 2022
Via
Investor Brand Network
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
August 10, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study...
Via
FinancialNewsMedia
Topics
Supply Chain
Exposures
Supply Chain
World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health
June 15, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a...
Via
FinancialNewsMedia
Oregon to Become the First State to Legally Roll Out Psilocybin
April 28, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 28, 2022 – Oregon is set to become the first US state to market legal psilocybin, the psychoactive substance found in...
Via
FinancialNewsMedia
Topics
Derivatives
ETFs
Exposures
Derivatives
Why MindMed’s LSD Trial for Anxiety May Be Important to Psychedelic Investors
April 21, 2022
Via
Investor Brand Network
Why Psychedelics Could Soon Replace Antidepressants
April 13, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults...
Via
FinancialNewsMedia
Demand for Toad Venom Rises Along With the Booming Psychedelics Market
March 30, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 30, 2022 – Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic...
Via
FinancialNewsMedia
NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Differentiates Itself in Psychedelics Space
March 07, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
NetworkNewsWire Editorial Coverage New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of...
Via
FinancialNewsMedia
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
January 19, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – January 19, 2022 – After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of...
Via
FinancialNewsMedia
A Recap of How Psychedelics Fared in 2021
January 07, 2022
Via
Investor Brand Network
Mind Medicine (NASDAQ: MNMD) (NEO: MMED) to Study Effect of Time on LSD Microdosing
December 17, 2021
Via
Investor Brand Network
Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) to Conduct Study Investigating Effect of Time on LSD Microdosing
December 16, 2021
Via
Investor Brand Network
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.